JPMorgan Chase & Co’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.1M Buy
764,997
+48,664
+7% +$2.8M ﹤0.01% 1273
2025
Q1
$41.7M Buy
716,333
+101,167
+16% +$5.89M ﹤0.01% 1268
2024
Q4
$49.5M Sell
615,166
-197,200
-24% -$15.9M ﹤0.01% 1185
2024
Q3
$65.1M Sell
812,366
-84,381
-9% -$6.76M ﹤0.01% 1062
2024
Q2
$54.8M Buy
896,747
+823,558
+1,125% +$50.3M ﹤0.01% 1096
2024
Q1
$3.62M Sell
73,189
-47,058
-39% -$2.33M ﹤0.01% 2769
2023
Q4
$5.04M Sell
120,247
-2,608
-2% -$109K ﹤0.01% 2556
2023
Q3
$4.03M Buy
122,855
+896
+0.7% +$29.4K ﹤0.01% 2556
2023
Q2
$4.31M Buy
121,959
+40,843
+50% +$1.44M ﹤0.01% 2591
2023
Q1
$2.3M Buy
81,116
+51,679
+176% +$1.47M ﹤0.01% 2963
2022
Q4
$1.22M Buy
29,437
+3,212
+12% +$133K ﹤0.01% 3251
2022
Q3
$1.09M Sell
26,225
-39,189
-60% -$1.62M ﹤0.01% 3291
2022
Q2
$2.14M Buy
65,414
+60,061
+1,122% +$1.96M ﹤0.01% 2961
2022
Q1
$188K Buy
5,353
+825
+18% +$29K ﹤0.01% 4481
2021
Q4
$113K Buy
+4,528
New +$113K ﹤0.01% 4769